ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026

ECLLA Team Attends EHA 2026 Congress in Stockholm 11–14, 2026

The ECLLA team proudly participated in the 31st Congress of the European Hematology Association (EHA 2026), held from June 11–14, 2026, in Stockholm, Sweden. As one of the world’s premier hematology events, EHA brings together leading experts, researchers,...
📍 Live from Stockholm!  Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”

📍 Live from Stockholm! Breakfast panel discussion on “Time-Limited Treatment in CLL: The Holistic Impact of Treatment-Free Periods for the Patient, the Care Partner and the Wider CLL Community”

Today, ECLLA is bringing together clinicians, patient advocates, care partners, nurse, and policy expert from across Europe for our multi-stakeholder panel discussion: “Time Off Treatment in CLL: Clinical Control and Patient Priorities in Fixed-Duration Treatment”...
ECLLA Newsletter – May 2026 Edition Now Available

ECLLA Newsletter – May 2026 Edition Now Available

The European CLL Association (ECLLA) is pleased to announce the release of the May 2026 edition of the ECLLA Newsletter. This edition highlights some of the key milestones, activities, and developments from ECLLA’s first months of activity, including the growth of the...